| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |








From The Scripps Research Institute,*
La Jolla,
California; the University of Washington,
Seattle, Washington; and the Technical University of
Dresden,
Dresden, Germany
Functional inhibition of tissue factor (TF) has been shown to improve coronary blood flow after myocardial ischemia/reperfusion (I/R) injury. TF initiates the coagulation protease cascade, resulting in the generation of the serine protease thrombin and fibrin deposition. Thrombin can also contribute to an inflammatory response by activating various cell types, including vascular endothelial cells. We used a rabbit coronary ligation model to investigate the role of TF in acute myocardial I/R injury. At-risk areas of myocardium showed increased TF expression in the sarcolemma of cardiomyocytes, which was associated with a low level of extravascular fibrin deposition. Functional inhibition of TF activity with an anti-rabbit TF monoclonal antibody administered either 15 minutes before or 30 minutes after coronary ligation reduced infarct size by 61% (P = 0.004) and 44% (P = 0.014), respectively. Similarly, we found that inhibition of thrombin with hirudin reduced infarct size by 59% (P = 0.014). In contrast, defibrinogenating the rabbits with ancrod had no effect on infarct size, suggesting that fibrin deposition does not significantly contribute to infarct size. Functional inhibition of thrombin reduced chemokine expression and inhibition of either TF or thrombin reduced leukocyte infiltration. We propose that cardiomyocyte TF initiates extravascular thrombin generation, which enhances inflammation and injury during myocardial I/R.
This article has been cited by other articles:
![]() |
C. Pinet, V. Algalarrondo, S. Sablayrolles, B. Le Grand, C. Pignier, D. Cussac, M. Perez, S. N. Hatem, and A. Coulombe Protease-Activated Receptor-1 Mediates Thrombin-Induced Persistent Sodium Current in Human Cardiomyocytes Mol. Pharmacol., June 1, 2008; 73(6): 1622 - 1631. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pawlinski, M. Tencati, C. R. Hampton, T. Shishido, T. A. Bullard, L. M. Casey, P. Andrade-Gordon, M. Kotzsch, D. Spring, T. Luther, et al. Protease-Activated Receptor-1 Contributes to Cardiac Remodeling and Hypertrophy Circulation, November 13, 2007; 116(20): 2298 - 2306. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jiang, A. Zatta, H. Kin, N. Wang, J. G. Reeves, J. Mykytenko, J. Deneve, Z.-Q. Zhao, R. A. Guyton, and J. Vinten-Johansen PAR-2 activation at the time of reperfusion salvages myocardium via an ERK1/2 pathway in in vivo rat hearts Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2845 - H2852. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sevastos, S. E. Kennedy, D. R. Davis, M. Sam, P. W. Peake, J. A. Charlesworth, N. Mackman, and J. H. Erlich Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury Blood, January 15, 2007; 109(2): 577 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Doukas, W. Wrasidlo, G. Noronha, E. Dneprovskaia, R. Fine, S. Weis, J. Hood, A. DeMaria, R. Soll, and D. Cheresh Phosphoinositide 3-kinase {gamma}/{delta} inhibition limits infarct size after myocardial ischemia/reperfusion injury PNAS, December 26, 2006; 103(52): 19866 - 19871. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cozzi, S. Hazarika, H. W. Stallings III, W. E. Cascio, R. B. Devlin, R. M. Lust, C. J. Wingard, and M. R. Van Scott Ultrafine particulate matter exposure augments ischemia-reperfusion injury in mice Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H894 - H903. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rafiq, M. A. Kolpakov, M. Abdelfettah, D. N. Streblow, A. Hassid, L. J. Dell'Italia, and A. Sabri Role of Protein-tyrosine Phosphatase SHP2 in Focal Adhesion Kinase Down-regulation during Neutrophil Cathepsin G-induced Cardiomyocytes Anoikis J. Biol. Chem., July 14, 2006; 281(28): 19781 - 19792. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Steffel, T. F. Luscher, and F. C. Tanner Tissue Factor in Cardiovascular Diseases: Molecular Mechanisms and Clinical Implications Circulation, February 7, 2006; 113(5): 722 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Eligini, F. Violi, C. Banfi, S. S. Barbieri, M. Brambilla, M. Saliola, E. Tremoli, and S. Colli Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism Cardiovasc Res, January 1, 2006; 69(1): 218 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Banz, O. M. Hess, S. C. Robson, D. Mettler, P. Meier, A. Haeberli, E. Csizmadia, E. Y. Korchagina, N. V. Bovin, and R. Rieben Locally targeted cytoprotection with dextran sulfate attenuates experimental porcine myocardial ischaemia/reperfusion injury Eur. Heart J., November 1, 2005; 26(21): 2334 - 2343. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zhang, X. Liu, J. G. Cogan, M. D. Fuerst, J. A. Polikandriotis, R. J. Kelm Jr., and A. R. Strauch YB-1 Coordinates Vascular Smooth Muscle {alpha}-Actin Gene Activation by Transforming Growth Factor {beta}1 and Thrombin during Differentiation of Human Pulmonary Myofibroblasts Mol. Biol. Cell, October 1, 2005; 16(10): 4931 - 4940. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suzuki, T. J. Moraes, E. Vachon, H. H. Ginzberg, T.-T. Huang, M. A. Matthay, M. D. Hollenberg, J. Marshall, C. A. G. McCulloch, M. T. H. Abreu, et al. Proteinase-Activated Receptor-1 Mediates Elastase-Induced Apoptosis of Human Lung Epithelial Cells Am. J. Respir. Cell Mol. Biol., September 1, 2005; 33(3): 231 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Raivio, R. Suojaranta-Ylinen, and A. H. Kuitunen Recombinant Factor VIIa in the Treatment of Postoperative Hemorrhage After Cardiac Surgery Ann. Thorac. Surg., July 1, 2005; 80(1): 66 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Olivero, C. Eigenbrot, R. Goldsmith, K. Robarge, D. R. Artis, J. Flygare, T. Rawson, D. P. Sutherlin, S. Kadkhodayan, M. Beresini, et al. A Selective, Slow Binding Inhibitor of Factor VIIa Binds to a Nonstandard Active Site Conformation and Attenuates Thrombus Formation in Vivo J. Biol. Chem., March 11, 2005; 280(10): 9160 - 9169. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Busch, I. Seitz, B. Steppich, S. Hess, R. Eckl, A. Schomig, and I. Ott Coagulation Factor Xa Stimulates Interleukin-8 Release in Endothelial Cells and Mononuclear Leukocytes: Implications in Acute Myocardial Infarction Arterioscler. Thromb. Vasc. Biol., February 1, 2005; 25(2): 461 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Loverre, P. Ditonno, A. Crovace, L. Gesualdo, E. Ranieri, P. Pontrelli, G. Stallone, B. Infante, A. Schena, S. Di Paolo, et al. Ischemia-Reperfusion Induces Glomerular and Tubular Activation of Proinflammatory and Antiapoptotic Pathways: Differential Modulation by Rapamycin J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2675 - 2686. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-L. Hemdahl, E. Falk, P. Thoren, and G. K. Hansson Thrombin inhibitor reduces myocardial infarction in apoE-/- x LDLR-/- mice Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H872 - H877. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pawlinski, B. Pedersen, G. Schabbauer, M. Tencati, T. Holscher, W. Boisvert, P. Andrade-Gordon, R. D. Frank, and N. Mackman Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia Blood, February 15, 2004; 103(4): 1342 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Colognato, J. R. Slupsky, M. Jendrach, L. Burysek, T. Syrovets, and T. Simmet Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells Blood, October 1, 2003; 102(7): 2645 - 2652. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kaur, R. C. Woodman, and P. Kubes P38 MAPK: critical molecule in thrombin-induced NF-kappa B-dependent leukocyte recruitment Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1095 - H1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Klarenbach, A. Chipiuk, R. C. Nelson, M. D. Hollenberg, and A. G. Murray Differential Actions of PAR2 and PAR1 in Stimulating Human Endothelial Cell Exocytosis and Permeability: The Role of Rho-GTPases Circ. Res., February 21, 2003; 92(3): 272 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Chong, T. H. Pohlman, C. R. Hampton, A. Shimamoto, N. Mackman, and E. D. Verrier Tissue factor and thrombin mediate myocardial ischemia-reperfusion injury Ann. Thorac. Surg., February 1, 2003; 75(2): S649 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kluft, R. Kleemann, and M.P.M. de Maat How best to counteract the enemies? By controlling inflammation in the coronary circulation Eur. Heart J. Suppl., November 1, 2002; 4(suppl_G): G53 - G65. [Abstract] [PDF] |
||||
![]() |
D. Bonderman, A. Teml, J. Jakowitsch, C. Adlbrecht, M. Gyongyosi, W. Sperker, H. Lass, W. Mosgoeller, D. H. Glogar, P. Probst, et al. Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque Blood, April 15, 2002; 99(8): 2794 - 2800. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Beranek Tissue Factor Identifies Cardiomyocyte Apoptotic Bodies in Reperfusion Injury Am. J. Pathol., April 1, 2002; 160(4): 1543 - 1544. [Full Text] [PDF] |
||||
![]() |
A. H.M Moons, M. Levi, and R. J.G Peters Tissue factor and coronary artery disease Cardiovasc Res, February 1, 2002; 53(2): 313 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kaur, R. C. Woodman, L. Ostrovsky, and P. Kubes Selective recruitment of neutrophils and lymphocytes by thrombin: a role for NF-{kappa}B Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H784 - H795. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |